Risankizumab-rzaa: A New Therapeutic Option for the Treatment of Crohn's Disease.

Published in: The Annals of pharmacotherapy (2022)

Risankizumab-rzaa is the most recent therapeutic advance for CD. It has a selective mechanism of action with a similar safety profile comparable with other currently approved advanced therapies.

Keyphrases

combination therapy
smoking cessation